Montreal, September 13, 2021 – In recent weeks, governments in both Quebec and the rest of Canada have expanded access to Hemlibra to patients with...
September 9, 2021, Montréal – The Canadian Hemophilia Society (CHS) was informed late yesterday by Canadian Blood Services (CBS) that access to Hemlibra (emicizumab) will...
August 20, 2021, Montréal – The Canadian Hemophilia Society – Quebec Chapter (CHSQ) has learned that the Québec Ministère de la Santé et des Services...
August 8, 2021, Montreal – There is still no word on access to Hemlibra from ministries of health in Quebec and the rest of Canada...
Jeremy Hall, who the CHS has watched grow up in its community, will finally see his dream come true: he will compete in the Tokyo...
Hello to all, Following its June 27 AGM, the CHS is pleased to announce the arrival of a new leadership on its Board of Directors....
CLICK HERE to access the CHS 2020 Annual Report and the complete Financial Statements.
Ferring says supply of DDAVP injectable to return in “one to two months” Montreal, June 23, 2021 – Ferring Canada, in discussions with the Canadian...
CLICK HERE to access the June 2021 review of novel treatments in haemophilia and other bleeding disorders by the European Haemophilia Consortium.
The CHS is pleased to share its brand new five-year strategic framework following an extensive strategic planning exercise held in 2020. The strategy is expressed...
On May 25, 2021, Canadian Blood Services (CBS) released its report on emicizumab (Hemlibra) to the provincial/territorial (P/T) Ministers of Health (except Quebec), recommending eligibility...
On May 25, 2021, Canadian Blood Services (CBS) released its recommendation on emicizumab (Hemlibra) to the provincial/territorial Ministers of Health. CBS recommends that emicizumab be listed...
Updated charts for products in the pipeline have been uploaded on the CHS website. The CHS publishes four charts, one each for clotting factor concentrates,...
CHS CONTACT is a year old! And what a year it has been on the news front! If we could have chosen the best year...
